<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD006796.pub4" GROUP_ID="PVD" ID="536307041016270415" MERGED_FROM="" MODIFIED="2016-06-01 14:04:13 +0100" MODIFIED_BY="Cathryn Broderick" REVIEW_NO="1281" REVMAN_SUB_VERSION="5.3.5 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="4.0">
<COVER_SHEET MODIFIED="2016-06-01 14:04:06 +0100" MODIFIED_BY="Cathryn Broderick">
<TITLE>Thoracic stent graft versus surgery for thoracic aneurysm</TITLE>
<CONTACT MODIFIED="2016-06-01 14:04:06 +0100" MODIFIED_BY="Cathryn Broderick"><PERSON ID="9AEC366382E26AA201E6E48B62121A66" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Alessandro</FIRST_NAME><LAST_NAME>Montedori</LAST_NAME><POSITION>Public Health Expert</POSITION><EMAIL_1>amontedori@regione.umbria.it</EMAIL_1><ADDRESS><DEPARTMENT>Health Planning Service</DEPARTMENT><ORGANISATION>Regional Health Authority of Umbria</ORGANISATION><ADDRESS_1>Via Mario Angeloni 61</ADDRESS_1><CITY>Perugia</CITY><ZIP>06124</ZIP><REGION>Umbria</REGION><COUNTRY CODE="IT">Italy</COUNTRY><PHONE_1>+39 075 5045217</PHONE_1><FAX_1>+39 075 5045569</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2016-06-01 14:04:06 +0100" MODIFIED_BY="Cathryn Broderick"><PERSON ID="6817165D82E26AA201DBBAAB29D7F431" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Iosief</FIRST_NAME><LAST_NAME>Abraha</LAST_NAME><EMAIL_1>iosief_a@yahoo.it</EMAIL_1><EMAIL_2>iabraha@regione.umbria.it</EMAIL_2><ADDRESS><ORGANISATION>Health Planning Service, Regional Health Authority of Umbria</ORGANISATION><CITY>Perugia</CITY><COUNTRY CODE="IT">Italy</COUNTRY></ADDRESS></PERSON><PERSON ID="2E94096E82E26AA20129AA21FBC9E245" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Carlo</FIRST_NAME><LAST_NAME>Romagnoli</LAST_NAME><EMAIL_1>carlo.romagnoli@uslumbria1.it</EMAIL_1><EMAIL_2>carloromag@yahoo.it</EMAIL_2><ADDRESS><DEPARTMENT>Epidemiological Planning</DEPARTMENT><ORGANISATION>USLUmbria1</ORGANISATION><CITY>Perugia</CITY><ZIP>06100</ZIP><COUNTRY CODE="IT">Italy</COUNTRY><PHONE_1>+39 075 5412485</PHONE_1></ADDRESS></PERSON><PERSON ID="9AEC366382E26AA201E6E48B62121A66" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Alessandro</FIRST_NAME><LAST_NAME>Montedori</LAST_NAME><POSITION>Public Health Expert</POSITION><EMAIL_1>amontedori@regione.umbria.it</EMAIL_1><ADDRESS><DEPARTMENT>Health Planning Service</DEPARTMENT><ORGANISATION>Regional Health Authority of Umbria</ORGANISATION><ADDRESS_1>Via Mario Angeloni 61</ADDRESS_1><CITY>Perugia</CITY><ZIP>06124</ZIP><REGION>Umbria</REGION><COUNTRY CODE="IT">Italy</COUNTRY><PHONE_1>+39 075 5045217</PHONE_1><FAX_1>+39 075 5045569</FAX_1></ADDRESS></PERSON><PERSON ID="D7301B7582E26AA20144426C7AECF8B2" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Roberto</FIRST_NAME><LAST_NAME>Cirocchi</LAST_NAME><POSITION>Professor in General Surgery,</POSITION><EMAIL_1>cirocchiroberto@yahoo.it</EMAIL_1><ADDRESS><DEPARTMENT>Department of General Surgery</DEPARTMENT><ORGANISATION>University of Perugia</ORGANISATION><CITY>Terni</CITY><ZIP>05100</ZIP><COUNTRY CODE="IT">Italy</COUNTRY><PHONE_1>+39 3290 1388 38</PHONE_1><FAX_1>+39 0744 2052 01</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2016-05-16 14:39:30 +0100" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="19" MONTH="1" YEAR="2016"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="19" MONTH="1" YEAR="2016"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="19" MONTH="1" YEAR="2018"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="4" YEAR="2007"/>
<REVIEW_PUBLISHED ISSUE="1" YEAR="2009"/>
<LAST_CITATION_ISSUE ISSUE="6" YEAR="2016"/>
</DATES>
<WHATS_NEW MODIFIED="2016-04-25 14:03:12 +0100" MODIFIED_BY="Karen Welch">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2016-04-25 14:03:12 +0100" MODIFIED_BY="Karen Welch">
<DATE DAY="19" MONTH="1" YEAR="2016"/>
<DESCRIPTION>
<P>Searches of CENTRAL and Specialised Register were rerun. No randomised controlled studies were found. Minor edits made. Conclusions not changed.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2016-04-25 13:47:55 +0100" MODIFIED_BY="Karen Welch">
<DATE DAY="19" MONTH="1" YEAR="2016"/>
<DESCRIPTION>
<P>Searches of CENTRAL and Specialised Register were rerun. No randomised controlled studies were found.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2013-03-13 10:54:33 +0000" MODIFIED_BY="Heather  Maxwell">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2013-03-13 10:54:33 +0000" MODIFIED_BY="Karen Welch">
<DATE DAY="29" MONTH="9" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2016-01-21 10:19:40 +0000" MODIFIED_BY="Cathryn  Broderick">
<INTERNAL_SOURCES/>
<EXTERNAL_SOURCES MODIFIED="2016-01-21 10:19:40 +0000" MODIFIED_BY="Cathryn  Broderick">
<SOURCE MODIFIED="2016-01-21 10:19:40 +0000" MODIFIED_BY="Cathryn  Broderick">
<NAME>Chief Scientist Office, Scottish Government Health Directorates, The Scottish Government</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION>
<P>The Cochrane Vascular editorial base is supported by the Chief Scientist Office.</P>
</DESCRIPTION>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2016-05-19 13:18:36 +0100" MODIFIED_BY="Cathryn  Broderick">
<SUMMARY MODIFIED="2016-05-16 14:39:50 +0100" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2008-10-20 03:29:16 +0100" MODIFIED_BY="[Empty name]">Thoracic endoscopic stent graft versus open surgery for thoracic aneurysm</TITLE>
<SUMMARY_BODY MODIFIED="2016-05-16 14:39:50 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Background</B>
</P>
<P>An aneurysm is a localised dilation or widening of an artery. Thoracic aneurysm is a relatively infrequent disease that affects both older men and women. The cause of thoracic aneurysm is unknown but the aneurysms generally do not cause symptoms. They are, however, likely to increase in size. Patients who do not receive surgical treatment at the time of diagnosis have a greater chance of dying from rupture of the aneurysm. Aneurysms greater than 5 cm carry a higher risk of bursting. Surgical repair of aneurysms requires general anaesthesia and opening of the chest wall to place an artificial graft in the area of the diseased vessel. This is associated with procedure-related deaths and complications such as paraplegia, stroke, and renal failure and excludes some patients because of age and accompanying illnesses. Endovascular repair is a recently introduced, minimally invasive technique in which a stent is delivered through a blood vessel and fixed to the aneurysm. A seal forms between the stent and the vessel wall so that blood does not flow between the two. We searched for evidence of the effectiveness of endovascular repair compared with open surgical repair for thoracic aneurysms.</P>
<P>
<B>Key results</B>
</P>
<P>No randomised controlled trials were found in the medical literature (current until January 2016). Reports from non-randomised studies suggest that endovascular repair is technically feasible and may reduce early negative outcomes including death and paraplegia. However, stent devices have late complications that are uncommon to open surgery (for example, development of leaks, graft migration, need for re-intervention) and patients receiving stents may require frequent surveillance with computed tomography (CT) scans.</P>
<P>
<B>Quality of the evidence</B>
</P>
<P>In the absence of studies eligible for inclusion in the review it was not possible to assess the quality of the evidence.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2016-05-04 16:11:49 +0100" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2016-05-04 16:11:21 +0100" MODIFIED_BY="[Empty name]">
<P>Thoracic aortic aneurysm (TAA) is an uncommon disease with an incidence of 10.4 per 100,000 inhabitants. It occurs mainly in older individuals and is evenly distributed among both sexes. There are no signs or symptoms indicative of the presence of the disease. Progressive but unpredictable enlargement of the dilated aorta is the natural course of the disease and can lead to rupture. Open chest surgical repair using prosthetic graft interposition has been a conventional treatment for TAAs. Despite improvements in surgical procedures perioperative complications remain significant. The alternative option of thoracic endovascular aneurysm repair (TEVAR) is considered a less invasive and potentially safer technique, with lower morbidity and mortality compared with conventional treatment. Evidence is needed to support the use of TEVAR for these patients, rather than open surgery. This is an update of the review first published in 2009.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2016-05-04 16:11:36 +0100" MODIFIED_BY="[Empty name]">
<P>This review aimed to assess the efficacy of TEVAR versus conventional open surgery in patients with thoracic aortic aneurysms.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2016-05-04 16:11:40 +0100" MODIFIED_BY="[Empty name]">
<P>For this update the Cochrane Vascular Information Specialist searched the Specialised Register (last searched January 2016) and CENTRAL (2015, Issue 12).</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2008-10-19 04:26:30 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trials in which patients with TAAs were randomly assigned to TEVAR or open surgical repair.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2008-10-15 09:38:11 +0100" MODIFIED_BY="Heather  Maxwell">
<P>Two review authors independently identified and evaluated potential trials for eligibility. Excluded studies were further checked by another author. We did not perform any statistical analyses as no randomised controlled trials were identified.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2008-10-10 15:19:28 +0100" MODIFIED_BY="Heather  Maxwell">
<P>We did not find any published or unpublished randomised controlled trials comparing TEVAR with conventional open surgical repair for the treatment of thoracic aortic aneurysms.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2016-05-04 16:11:49 +0100" MODIFIED_BY="[Empty name]">
<P>Stent grafting of the thoracic aorta is technically feasible and non-randomised studies suggest reduction of early outcomes such as paraplegia, mortality and hospital stay. High quality randomised controlled trials assessing all clinically relevant outcomes including open-conversion, aneurysm exclusion, endoleaks, and late mortality are needed.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2016-05-16 14:54:49 +0100" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2013-08-22 11:16:38 +0100" MODIFIED_BY="Heather  Maxwell">
<CONDITION MODIFIED="2013-08-22 11:16:38 +0100" MODIFIED_BY="Heather  Maxwell">
<P>Aneurysms are usually defined as a permanent localised dilation of an artery where the diameter is at least 50% greater than the expected normal size of the artery. The majority of aortic aneurysms are localised in the abdominal aorta, but the thoracic part of the aorta is not immune to vascular degeneration. Thoracic aortic aneurysms (TAAs) are usually associated with atherosclerosis. Due to the uncommon nature of the disease the data on natural history, prevalence, and mortality are limited and sometimes differ. A study published in 1982 reported an incidence of TAAs of 5.9 per 100,000 in a stable community over 30 years of observation (<LINK REF="REF-Bickerstaff-1982" TYPE="REFERENCE">Bickerstaff 1982</LINK>), while another survey documented an incidence of 10.4 per 100,000 from 1980 to 1994 (<LINK REF="REF-Clouse-1998" TYPE="REFERENCE">Clouse 1998</LINK>). The two-fold increase in the incidence of TAAs may be attributed to the advent of more sophisticated diagnostic instruments, such as computed tomography (CT), or the result of an aging population. However, according to some reports, TAAs occur mainly in older individuals and, contrary to abdominal aortic aneurysms which affect mainly males, the incidence of TAAs is evenly distributed among both sexes (<LINK REF="REF-Bickerstaff-1982" TYPE="REFERENCE">Bickerstaff 1982</LINK>; <LINK REF="REF-Clouse-1998" TYPE="REFERENCE">Clouse 1998</LINK>).</P>
<P>Given the silent nature of TAAs it is difficult to identify signs and symptoms that warn of the presence of the disease. Most of the time such aneurysms are diagnosed by chance. When the diagnosis is made, identification of factors that might help us to recognise patients who are in most need of treatment, or who are at high risk of rupture, is necessary. While age, the presence of hypertension, chronic obstructive pulmonary disease, and renal failure have been identified as risk factors associated with aneurysmal disease and its rupture, the diameter of the aneurysm is the most important predictor to be considered when evaluating patients with TAAs (<LINK REF="REF-Griepp-1999" TYPE="REFERENCE">Griepp 1999</LINK>). A number of retrospective studies have documented that the size of the aortic aneurysm is the major factor predicting rupture. Although small aneurysms may rupture, risk of rupture and mortality related to rupture become significant when the diameter of the affected aorta exceeds 5 cm (<LINK REF="REF-Cambria-1995" TYPE="REFERENCE">Cambria 1995</LINK>; <LINK REF="REF-Coady-1997" TYPE="REFERENCE">Coady 1997</LINK>; <LINK REF="REF-Lobato-1998" TYPE="REFERENCE">Lobato 1998</LINK>; <LINK REF="REF-Perko-1995" TYPE="REFERENCE">Perko 1995</LINK>). The five-year mortality rate of aneurysms exceeding 6 cm varies from 38% to 64% (<LINK REF="REF-Coady-1997" TYPE="REFERENCE">Coady 1997</LINK>; <LINK REF="REF-Joyce-1964" TYPE="REFERENCE">Joyce 1964</LINK>). In addition, the rate of increase in the size of aortic aneurysms is part of the natural course of the disease and is an another indicator that predicts rupture. Indeed, TAAs may have an expansion rate of between 0.2 cm and 0.4 cm per year. Growth rate is directly related to the initial size of the diseased aorta (<LINK REF="REF-Cambria-1995" TYPE="REFERENCE">Cambria 1995</LINK>; <LINK REF="REF-Coady-1997" TYPE="REFERENCE">Coady 1997</LINK>; <LINK REF="REF-Hirose-1993" TYPE="REFERENCE">Hirose 1993</LINK>). Some authors estimate that each 1 cm increase in the size of the thoracic aneurysm is translated into a further increase in the probability of rupture by a factor of 1.9, compared with a factor of 1.5 observed for abdominal aneurysms (<LINK REF="REF-Juvonen-1997" TYPE="REFERENCE">Juvonen 1997</LINK>).</P>
<P>Data from several retrospective surveys indicate that for patients who did not receive surgery at the time of diagnosis, rupture was the most common cause of death, with death rates ranging from 42% to 74% (<LINK REF="REF-Bickerstaff-1982" TYPE="REFERENCE">Bickerstaff 1982</LINK>; <LINK REF="REF-Crawford-1986" TYPE="REFERENCE">Crawford 1986</LINK>; <LINK REF="REF-Perko-1995" TYPE="REFERENCE">Perko 1995</LINK>). The five-year survival rate was 39% for patients with TAAs and 23% for those with thoracoabdominal aneurysm (<LINK REF="REF-Perko-1995" TYPE="REFERENCE">Perko 1995</LINK>). When rupture occurs, patients mostly die within six hours and, although 46% of patients arrive alive at the hospital, the overall mortality rate of ruptured TAAs reaches 97% (<LINK REF="REF-Johansson-1995" TYPE="REFERENCE">Johansson 1995</LINK>).</P>
</CONDITION>
<INTERVENTION MODIFIED="2008-11-05 12:30:29 +0000" MODIFIED_BY="Heather  Maxwell">
<P>The high mortality of aneurysmal disease has lead many to suggest surgical repair of the dilated aorta, even though the anatomical morphology of the thoracic aorta together with the characteristics of patients affected by TAAs pose a considerable challenge to surgeons. Open surgical repair using prosthetic graft interposition is the conventional treatment for TAAs mainly because of its feasibility and effectiveness in excluding the degenerated aorta from the systemic circulation. Open surgical repair of TAAs is associated with significant perioperative complications including 30-day mortality and paraplegia, with rates of 4.8% and 4.6% respectively. Stroke and renal failure are also important complications to be considered (<LINK REF="REF-Coselli-2000" TYPE="REFERENCE">Coselli 2000</LINK>; <LINK REF="REF-Deeb-1995" TYPE="REFERENCE">Deeb 1995</LINK>; <LINK REF="REF-LeMaire-2003" TYPE="REFERENCE">LeMaire 2003</LINK>). Despite noteworthy improvements in surgical procedures with extracorporeal circulation for peripheral organ preservation, the development of different techniques for spinal cord protection, together with the refinement of prosthetic grafts for aortic repair, morbidity and mortality rates remain high (<LINK REF="REF-Hamerlijnck-1989" TYPE="REFERENCE">Hamerlijnck 1989</LINK>; <LINK REF="REF-Huynh-2002" TYPE="REFERENCE">Huynh 2002</LINK>; <LINK REF="REF-Thurnher-2002" TYPE="REFERENCE">Thurnher 2002</LINK>).</P>
</INTERVENTION>
<THEORY MODIFIED="2008-10-19 05:05:21 +0100" MODIFIED_BY="[Empty name]">
<P>In view of these complexities, and the fact that many high risk patients were regularly excluded from open surgical repair, a less invasive and potentially safer technique became imperative. Thus an alternative for open surgical repair for aortic aneurysm has become the performance of endovascular repair using stent grafts. The aim of this technique is to reach the target site by performing an access through a remote vessel to deliver the stent, secure endograft fixation, and allow the formation of a haemostatic seal between the graft and the vessel wall. The endovascular repair (EVAR) technique has been successfully used in the treatment of abdominal aortic aneurysms and with respect to conventional open surgical repair has been shown to reduce early post-operative complications and death (<LINK REF="REF-Greenhalgh-2004" TYPE="REFERENCE">Greenhalgh 2004</LINK>; <LINK REF="REF-Prinssen-2004" TYPE="REFERENCE">Prinssen 2004</LINK>). The success of the stent-graft placement performed in abdominal aortic aneurysms prompted experts to translate the technique to thoracic aneurysm repair. Dake was the first to report the use of stent graft in 13 patients with TAAs with positive outcomes over 11 months of observation (<LINK REF="REF-Dake-1994" TYPE="REFERENCE">Dake 1994</LINK>).</P>
<P>Identification of the best vascular access through which to deliver the stent is important, as well as performing imaging studies that help assess the best site for the insertion of the stent-graft delivery system. Non-surgical repair may be an attractive therapeutic option for patients with TAAs. According to some authors the morbidity and mortality associated with EVAR of thoracic aneurysm (TEVAR) appear to be less than with conventional treatment. In addition, while mid-term survival seems satisfactory in patients receiving endovascular treatment the long-term outcomes for high risk patients are disappointing, probably due to co-existing disease (<LINK REF="REF-Demers-2004" TYPE="REFERENCE">Demers 2004</LINK>; <LINK REF="REF-Ehrlich-1998" TYPE="REFERENCE">Ehrlich 1998</LINK>; <LINK REF="REF-Greenberg-2000" TYPE="REFERENCE">Greenberg 2000</LINK>; <LINK REF="REF-Marcheix-2006" TYPE="REFERENCE">Marcheix 2006</LINK>; <LINK REF="STD-Mitchell-1999" TYPE="STUDY">Mitchell 1999</LINK>).</P>
</THEORY>
<IMPORTANCE MODIFIED="2008-10-19 05:07:50 +0100" MODIFIED_BY="[Empty name]">
<P>Thus, convincing evidence that TEVAR is better than open surgical treatment for TAAs is needed. Potential advantages of TEVAR include reduction in the rate of paraplegia; reduced time under anaesthesia; avoidance of arterial cross-clamping, renal failure, and cardiovascular complications; reduced length of hospital stay, and particularly a reduction in the length of stay in an intensive care unit.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2016-05-04 16:22:01 +0100" MODIFIED_BY="[Empty name]">
<P>This review aimed to assess the efficacy of thoracic endovascular aneurysm repair (TEVAR) versus conventional open surgery in patients with thoracic aortic aneurysms (TAA).</P>
</OBJECTIVES>
<METHODS MODIFIED="2016-05-16 14:54:49 +0100" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2016-05-16 14:53:31 +0100" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2008-10-10 15:45:02 +0100" MODIFIED_BY="Heather  Maxwell">
<P>Randomised controlled trials (RCTs) evaluating TEVAR compared with conventional open surgical repair.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2008-10-19 05:09:19 +0100" MODIFIED_BY="[Empty name]">
<P>All asymptomatic patients in whom a thoracic aortic aneurysm was diagnosed by computed tomography (CT), magnetic resonance angiography (MRA), or conventional angiography. Only studies reporting the size of TAAs were eligible for consideration.<BR/>
<BR/>Mycotic aneurysms (aneurysms caused by an infection of the arterial wall or when a pre-existing aneurysm has become secondarily infected), acute or chronic dissections, and all patients with connective tissue disorders were excluded.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2008-10-19 05:09:44 +0100" MODIFIED_BY="[Empty name]">
<P>All types of endovascular devices were considered when compared with conventional open surgical treatment.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2016-05-16 14:53:31 +0100" MODIFIED_BY="[Empty name]">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2016-05-16 14:53:31 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>short-term mortality rates (30 days, or in hospital, i.e. procedure related);</LI>
<LI>aneurysm exclusion (no flow in the aneurysmal sac or extravasations (discharge of blood from a vessel to the tissues) beyond the sac) on follow-up imaging 30 days after the procedure;</LI>
<LI>major complications (haemorrhage, open conversion, myocardial infarction, stroke, renal failure, respiratory failure, spinal chord ischaemia, bowel ischaemia, lower limb ischaemia).</LI>
</UL>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2016-05-16 14:53:27 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>minor complications;</LI>
<LI>long-term complications and mortality (re-intervention rates for problems related to the TAA or its treatment were sought where possible, as was cause of death with or without re-intervention, i.e. device related);</LI>
<LI>quality of life (based on validated questionnaires).</LI>
</UL>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2016-05-16 14:51:27 +0100" MODIFIED_BY="[Empty name]">
<ELECTRONIC_SEARCHES MODIFIED="2016-05-16 14:51:27 +0100" MODIFIED_BY="[Empty name]">
<P>For this update the Cochrane Vascular Information Specialist (CIS) searched the Specialised Register (January 2016). In addition the CIS searched the Cochrane Register of Studies (CRS) <A HREF="http://www.metaxis.com/CRSWeb/Index.asp">http://www.metaxis.com/CRSWeb/Index.asp</A> (CENTRAL (2015, Issue 12)). See <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK> for details of the search strategy used to search the CRS. The Specialised Register is maintained by the CIS and is constructed from weekly electronic searches of MEDLINE, EMBASE, CINAHL, AMED, and through handsearching relevant journals. The full list of the databases, journals and conference proceedings which have been searched, as well as the search strategies used are described in the <A HREF="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/PVD/frame.html">Specialised Register</A> section of the Cochrane Vascular module in the<I> Cochrane Library</I> (<A HREF="http://www.cochranelibrary.com/">www.cochranelibrary.com</A>).</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2016-04-25 13:49:19 +0100" MODIFIED_BY="Karen Welch">
<P>The reference lists of all relevant studies found were screened. </P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2016-05-16 14:54:49 +0100" MODIFIED_BY="[Empty name]">
<STUDY_SELECTION MODIFIED="2016-04-25 13:50:51 +0100" MODIFIED_BY="Karen Welch">
<P>Two authors (IA and RC) assessed all studies identified from the literature search. Disagreements were resolved through discussion with the review team and the agreed arbitrator (AM).</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2016-05-04 16:23:41 +0100" MODIFIED_BY="[Empty name]">
<P>Where eligible studies were identified, we planned for two review authors (IA and CR) to independently extract data. We planned to use a standard data extraction form to extract the following information: characteristics of the study (design, method of randomisation, blinding of outcome evaluators, and balance of prognostic factors (age, sex, size of the aneurysm)); participants; interventions; outcomes (types of outcome measures, adverse events). We planned to contact the authors of trials when these information were incomplete. We planned to resolve any disagreement by discussion. </P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2016-03-08 10:19:59 +0000" MODIFIED_BY="[Empty name]">
<P>For the assessment of study quality, we planned to use the risk of bias approach for Cochrane reviews (<A HREF="http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD010222.pub3/full#CD010222-bbs2-0016">Higgins 2011</A>) based on the assessment of the following domains of each included study: sequence generation, allocation concealment, blinding of participants, personnel and outcome assessors, incomplete outcome data, selective reporting bias, and other potential sources of bias (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).</P>
<P>We planned for two authors to independently evaluate the risk of bias of the included studies. Any disagreements were to be resolved by discussion or by a third review author.</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2016-05-04 16:23:46 +0100" MODIFIED_BY="[Empty name]">
<P>We planned to carry-out meta-analyses of primary and secondary outcomes. For the analysis of dichotomous outcomes, we planned to use risk ratios with 95% confidence intervals (CI); for the analysis of continuous outcomes, we planned to use the mean difference (MD) or standardised mean difference (SMD) and 95% CI.</P>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2016-05-04 19:52:43 +0100" MODIFIED_BY="[Empty name]">
<P>The unit of analysis was planned to be each participant recruited into the trials.</P>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2016-05-04 16:23:49 +0100" MODIFIED_BY="[Empty name]">
<P>In the event of missing data, we planned to contact the corresponding authors to try to obtain the relevant information.</P>
<P>We will not use any imputation methods. We preferred the intention-to-treat data where this approach was available. Where intention-to-treat data are not available, we planned to conduct analyses using data of available cases.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2016-05-16 14:54:49 +0100" MODIFIED_BY="[Empty name]">
<P>We planned to consider whether the clinical and methodological characteristics of the studies were sufficiently homogeneous to pool data in a meta-analysis. We planned to quantify inconsistency among the pooled estimates using the I<SUP>2</SUP> statistic.</P>
<P>We planned to consider a Chi<SUP>2</SUP> test with a P value of 0.10 to be significant, and interpret the I<SUP>2 </SUP>statistic as: 0% to 40% unimportant heterogeneity; 30% to 60% moderate heterogeneity; 50% to 90% substantial heterogeneity; and 75% to 100% considerable heterogeneity.</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2016-03-08 11:06:44 +0000" MODIFIED_BY="[Empty name]">
<P>Where there are more than 10 studies that can be combined into a meta-analysis, we planned to use a funnel plot to examine for small-study effects, which may indicate publication bias.</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2016-05-04 16:23:53 +0100" MODIFIED_BY="[Empty name]">
<P>We planned to use the fixed-effect model to pool the data for each outcome. Where important or substantial heterogeneity (for example I<SUP>2</SUP> greater than 50%) was detected, we planned to meta-analyse data of the treatment effect using a random-effects model (with two or more studies).</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2016-05-04 19:52:04 +0100" MODIFIED_BY="[Empty name]">
<P>Where sufficient data are available, we plan to perform subgroup analyses based on several participant characteristics such as sex, the size of the aneurysm, its anatomical localisation (ascending, descending, or thoracoabdominal) and condition of patients (high risk versus low risk), and characteristics of the intervention (such as fenestrated or branched endografts bifurcated stent graft).</P>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2016-05-04 10:50:28 +0100" MODIFIED_BY="Cathryn  Broderick">
<P>Where a sufficient number of studies was available, we planned to perform sensitivity analyses to assess the consistency and robustness of the results of the meta-analyses based on the following scenarios: including only studies with low risk of selection bias (sequence generation and allocation concealment) (<LINK REF="REF-Wood-2008" TYPE="REFERENCE">Wood 2008</LINK>); including only trials with low risk of detection bias (blinding of outcome assessor) (<LINK REF="REF-Savovic-2012" TYPE="REFERENCE">Savovic 2012</LINK>); including only trials with low risk of attrition of bias; including only trials that did not deviate from intention-to-treat analysis (<LINK REF="REF-Abraha-2015" TYPE="REFERENCE">Abraha 2015</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="3">Summary of findings</HEADING>
<P>We planned to present the main findings of the review results concerning the quality of evidence, the magnitude of effect of the interventions examined, and the sum of available data on the primary outcomes (<LINK TAG="CRIT_OUTCOMES" TYPE="SECTION">Types of outcome measures</LINK>) in a 'Summary of findings' table, according to the GRADE principles as described by <LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK> and <LINK REF="REF-Atkins-2004" TYPE="REFERENCE">Atkins 2004</LINK>. Since we planned to assess different comparisons of interventions, we planned to develop a 'Summary of findings' table for each comparison using the GRADEpro software (<LINK REF="REF-GRADEproGDT" TYPE="REFERENCE">GRADEproGDT</LINK>), to assist in the preparation of the 'Summary of findings' table.</P>
</SUBSECTION>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2016-05-04 19:38:20 +0100" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2016-05-04 10:20:42 +0100" MODIFIED_BY="Cathryn  Broderick">
<P>See <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>.</P>
<SEARCH_RESULTS MODIFIED="2013-06-25 13:36:59 +0100" MODIFIED_BY="Cathryn  A Broderick">
<P>No studies were identified that met any of the inclusion criteria. A number of case series, cohort studies, and controlled studies with historic controls were found. These were excluded because of lack of randomisation (<I>see </I>
<LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>).</P>
</SEARCH_RESULTS>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2013-06-25 13:37:38 +0100" MODIFIED_BY="Cathryn  A Broderick">
<P>It was not possible to review methodological quality in the absence of studies eligible for inclusion in the review. </P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2016-05-04 19:38:20 +0100" MODIFIED_BY="[Empty name]">
<P>No published or unpublished randomised controlled trials were found comparing thoracic endovascular aneurysm repair (TEVAR) with conventional open surgical repair for the treatment of thoracic aortic aneurysms (TAAs).</P>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2016-05-04 19:52:52 +0100" MODIFIED_BY="[Empty name]">
<SUMMARY_OF_RESULTS MODIFIED="2016-05-04 19:38:26 +0100" MODIFIED_BY="[Empty name]">
<P>Thoracic surgery for the treatment of aneurysms is performed in a complex setting and entails general anaesthesia, thoracotomy with extensive surgical resection, left lung collapse, and aortic cross-clamping. As a result, important postoperative complications such as haemorrhage, spinal cord injury, stroke, and renal insufficiency must be considered. Distal aortic perfusion, cerebrospinal drainage, and intercostal artery implantation are some of the advances made to avoid complications associated with thoracic surgery but morbidity remains high. Moreover, factors such as the age of the patient and the presence of serious co-morbidities such as coronary heart disease, chronic lung disease, diabetes, and hypertension may exclude a number of patients from receiving surgical treatment.</P>
<P>The advent of endovascular stent interposition, first described by Parodi (<LINK REF="REF-Parodi-1991" TYPE="REFERENCE">Parodi 1991</LINK>) for abdominal aneurysm and later by Dake (<LINK REF="REF-Dake-1994" TYPE="REFERENCE">Dake 1994</LINK>) for the thoracic tract, has generated great interest among thoracic surgeons. This is mainly because an endovascular stent is considered a minimally invasive device and therefore, a good alternative for patients affected by thoracic aortic aneurysms (TAAs) who are not suitable for open surgical treatment.</P>
<P>This review documents that there are no published or pending randomised controlled trials that compare thoracic endovascular aneurysm repair (TEVAR) with open surgical treatment for patients with TAAs, assessing early and late mortality and major complications. Most of the current information relating to endovascular intervention comes from reports of case series, observational studies, or registry data with differing presentations.</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2016-04-16 15:08:39 +0100" MODIFIED_BY="[Empty name]">
<P>There is currently no evidence from randomised controlled trials.</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2016-05-04 19:38:31 +0100" MODIFIED_BY="[Empty name]">
<P>It was not possible to review methodological quality or the quality of the evidence in the absence of studies eligible for inclusion in the review.</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2016-04-16 15:09:49 +0100" MODIFIED_BY="[Empty name]">
<P>Potential biases in the review process were minimised by performing extensive literature search.</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2016-05-04 19:52:52 +0100" MODIFIED_BY="[Empty name]">
<P>Although no RCTs comparing TEVAR with open surgical treatment for patients with TAAs were identified, at least two controlled clinical trials can be mentioned. The first study, published in 2002, compared 19 patients who received endovascular stents with an historic cohort of 10 patients who received open surgical repair. Endovascular deployment was successful in all but one patient and early outcomes such as mean length of intensive care unit stay and hospital stay were better in the TEVAR group. The study, however, was not randomised and follow up was limited (<LINK REF="STD-Najibi-2002" TYPE="STUDY">Najibi 2002</LINK>).</P>
<P>The second trial, published in 2005, started as a prospective non-randomised multicenter phase II study. Promising results in terms of technical success and positive early outcomes prompted the FDA to approve the Gore TAG thoracic endoprosthesis (<LINK REF="STD-Makaroun-2005" TYPE="STUDY">Makaroun 2005</LINK>). At a later stage the study became a controlled trial in which the data of the 142 patients were compared with 94 controls (<LINK REF="STD-Bavaria-2007" TYPE="STUDY">Bavaria 2007</LINK>). According to the final analysis of the trial, mortality at 30 days was better in the endograft group, as well as other outcomes such as paraplegia and the length of hospital stay. However, the two-year survival rate was similar in the two groups. The significant limitations of the trial were that it was not a randomised trial; at least half of the control group was historical, which may augment further the selection bias; and symptomatic aneurysms were significantly higher in the open surgical cohort (38% versus 21%). In addition, data on aortic characteristics were unavailable in many of the control patients and the follow up was limited to two years, within which time 17% of the patients had exclusion of their aneurysm of a size greater than 0.5 cm, and at least 17% of the patients were lost to follow up (<LINK REF="STD-Bavaria-2007" TYPE="STUDY">Bavaria 2007</LINK>).</P>
<P>Despite the reported early advantages, stent devices for thoracic aneurysm have late complications that are uncommon with open surgery. Such complications include endoleaks, graft migration, stent fractures, and aneurysm-related death. Type I or attachment site endoleak is the most frequent complication and its incidence may reach 30% of cases (<LINK REF="REF-Neuhauser-2005" TYPE="REFERENCE">Neuhauser 2005</LINK>). Usually Type I endoleaks require additional stent-graft deployment for sealing or spot coiling, but sometimes such endoleaks may close spontaneously due to the formation of spontaneous thrombosis of the aortic false lumen and not require any further treatment. While resolution may occur within one week to eight months, endoleaks may progress with dilatation of the false lumen necessitating close follow up, supplementary procedures, or even open surgical treatment.</P>
<P>The available controlled clinical trials on TEVAR efficacy had promising results in terms of early mortality and reduction in postoperative complications but they failed to give generalisable conclusions, not only because of their internal low methodological quality but also in that high risk patients were not the target population. This reduces the original expectation that stent grafts could be an alternative for patients excluded from open surgical treatment because of their high risk status. The recent report of the Society of Thoracic Surgeons in fact states that the indication for stent grafting of a thoracic aortic aneurysm should be based on a predicted operative risk that is clearly lower than the risk of either conventional open repair or optimal medical management (<LINK REF="REF-Svensson-2008" TYPE="REFERENCE">Svensson 2008</LINK>). To this it must be added that patients who receive TEVAR will be in need of frequent surveillance CT scans after the intervention is performed and at a later stage they will probably need surgical re-intervention.</P>
<P>Although graft stenting for TAAs is technically feasible and may reduce the number and of severity of early outcomes, high quality randomised controlled trials assessing all clinically relevant outcomes, including early and late mortality, open conversion, aneurysm exclusion, endoleaks, are needed.</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2016-05-04 19:38:48 +0100" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2016-05-04 19:38:48 +0100" MODIFIED_BY="[Empty name]">
<P>Technically, endovascular repair of thoracic aneurysms may be a good alternative to open surgical repair. However, its benefit cannot be established as there are no published randomised controlled trials. The available information comes from non-randomised studies, which show benefit in terms of early mortality and complications such as paraplegia. Although such evidence may suggest that endovascular repair can be appropriate in selected patients, high quality studies are needed to produce generalisable conclusions.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2008-10-19 05:50:14 +0100" MODIFIED_BY="[Empty name]">
<P>High quality randomised controlled trials evaluating thoracic endovascular aneurysm repair (TEVAR) for thoracic aortic aneurysms are needed. These prospective trials should have adequate follow up, enough to evaluate the durability of endovascular treatment in terms of endoleak rate, re-intervention rate, open-conversion rate, and rupture-free survival. In addition, clinically relevant outcomes including early and late mortality, major complications, and hospital and intensive care unit stay must be considered. However, it would probably be extremely difficult to perform a randomised trial given the current stage of surgical endovascular practice.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS/>
<CONFLICT_OF_INTEREST MODIFIED="2016-05-19 13:18:36 +0100" MODIFIED_BY="Cathryn  Broderick">
<P>Dr Iosief Abraha: none known<BR/>Dr Carlo Romagnoli: none known<BR/>Dr Roberto Cirocchi: none known<BR/>Dr Alessandro Montedori: none known</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2016-05-11 12:06:35 +0100" MODIFIED_BY="Cathryn  Broderick">
<P>Dr Iosief Abraha: selected and assessed trials for possible inclusion; and wrote the majority of the text of this review<BR/>Dr Carlo Romagnoli: prepared the abstract and approved the final version <BR/>Dr Roberto Cirocchi: selected and assessed trials for possible inclusion; and approved the final version<BR/>Dr Alessandro Montedori: resolved any differences in the assessment of trials, helped in writing the 'Description of studies', wrote the 'Plain language summary'; and approved the final version<BR/>
</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2016-05-11 12:09:37 +0100" MODIFIED_BY="Cathryn  Broderick">
<P>Economic analysis was removed as a secondary outcome for this 2016 update as Cochrane Vascular does not have the expertise to carry out complete economic evaluations. Economic data available from studies identified for future updates will be included in the discussion section.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2016-06-01 14:04:13 +0100" MODIFIED_BY="Cathryn Broderick">
<STUDIES MODIFIED="2016-05-04 11:10:47 +0100" MODIFIED_BY="Cathryn  Broderick">
<INCLUDED_STUDIES/>
<EXCLUDED_STUDIES MODIFIED="2016-05-04 11:10:47 +0100" MODIFIED_BY="Cathryn  Broderick">
<STUDY DATA_SOURCE="PUB" ID="STD-Appoo-2006" MODIFIED="2008-10-19 03:54:19 +0100" MODIFIED_BY="[Empty name]" NAME="Appoo 2006" YEAR="2006">
<REFERENCE MODIFIED="2008-10-19 03:54:19 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Appoo JJ, Moser WG, Fairman RM, Cornelius KF, Pochettino A, Woo EY, et al. Thoracic aortic stent grafting: improving results with newer generation investigational devices. J Thorac Cardiovasc Surg. 2006 May;131(5):1087-94.&lt;br&gt;Appoo JJ. Moser WG. Fairman RM. Cornelius KF. Pochettino A. Woo EY. Kurichi JE. Carpenter JP. Bavaria JE. Thoracic aortic stent grafting: improving results with newer generation investigational devices. [Journal Article] Journal of Thoracic &amp;amp; Cardiovascular Surgery. 131(5):1087-94, 2006 May&lt;/p&gt;" NOTES_MODIFIED="2008-10-19 03:54:19 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Appoo JJ, Moser WG, Fairman RM, Cornelius KF, Pochettino A, Woo EY, et al</AU>
<TI>Thoracic aortic stent grafting: improving results with newer generation investigational devices</TI>
<SO>Journal of Thoracic and Cardiovascular Surgery</SO>
<YR>2006</YR>
<VL>131</VL>
<NO>5</NO>
<PG>1087-94</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2858469"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2858468"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Azizzadeh-2003" MODIFIED="2008-10-13 15:22:04 +0100" MODIFIED_BY="Heather  Maxwell" NAME="Azizzadeh 2003" YEAR="2003">
<REFERENCE MODIFIED="2008-10-13 15:22:04 +0100" MODIFIED_BY="Heather  Maxwell" NOTES="&lt;p&gt;Azizzadeh A, Huynh TTT, Miller CC, 3rd, Estrera AL, Porat EE, Sheinbaum R, et al. Postoperative risk factors for delayed neurologic deficit after thoracic and thoracoabdominal aortic aneurysm repair: a case-control study. J Vasc Surg. 2003 Apr;37(4):750-4.&lt;br&gt;Azizzadeh A. Huynh TT. Miller CC 3rd. Estrera AL. Porat EE. Sheinbaum R. Safi HJ. Postoperative risk factors for delayed neurologic deficit after thoracic and thoracoabdominal aortic aneurysm repair: a case-control study. [Journal Article] Journal of Vascular Surgery. 37(4):750-4, 2003 Apr.&lt;/p&gt;" NOTES_MODIFIED="2008-10-13 15:22:04 +0100" NOTES_MODIFIED_BY="Heather  Maxwell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Azizzadeh A, Huynh TT, Miller CC 3rd, Estrera AL, Porat EE, Sheinbaum R, et al</AU>
<TI>Postoperative risk factors for delayed neurologic deficit after thoracic and thoracoabdominal aortic aneurysm repair: a case-control study</TI>
<SO>Journal of Vascular Surgery</SO>
<YR>2003</YR>
<VL>37</VL>
<NO>4</NO>
<PG>750-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2858471"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2858470"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bavaria-2007" MODIFIED="2016-05-04 11:10:47 +0100" MODIFIED_BY="Cathryn  Broderick" NAME="Bavaria 2007" YEAR="2007">
<REFERENCE MODIFIED="2016-05-04 11:10:47 +0100" MODIFIED_BY="Cathryn  Broderick" NOTES="&lt;p&gt;Bavaria JE, Appoo JJ, Makaroun MS, Verter J, Yu ZF, Mitchell RS. Endovascular stent grafting versus open surgical repair of descending thoracic aortic aneurysms in low-risk patients: a multicenter comparative trial. The Journal of thoracic and cardiovascular surgery. 2007 Feb;133(2):369-77.&lt;br&gt;Bavaria JE. Appoo JJ. Makaroun MS. Verter J. Yu ZF. Mitchell RS. Gore TAG Investigators. Endovascular stent grafting versus open surgical repair of descending thoracic aortic aneurysms in low-risk patients: a multicenter comparative trial.[see comment]. [Clinical Trial, Phase II. Comparative Study. Journal Article. Multicenter Study. Research Support, Non-U.S. Gov't] Journal of Thoracic &amp;amp; Cardiovascular Surgery. 133(2):369-77, 2007 Feb.&lt;/p&gt;" NOTES_MODIFIED="2016-05-04 11:10:47 +0100" NOTES_MODIFIED_BY="Cathryn  Broderick" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bavaria JE, Appoo JJ, Makaroun MS, Verter J, Yu ZF, Mitchell RS</AU>
<TI>Endovascular stent grafting versus open surgical repair of descending thoracic aortic aneurysms in low-risk patients: a multicenter comparative trial</TI>
<SO>Journal of Thoracic and Cardiovascular Surgery</SO>
<YR>2007</YR>
<VL>133</VL>
<NO>2</NO>
<PG>369-77</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2858473"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2858472"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cambria-2002" MODIFIED="2008-10-13 15:22:22 +0100" MODIFIED_BY="Heather  Maxwell" NAME="Cambria 2002" YEAR="2002">
<REFERENCE MODIFIED="2008-10-13 15:22:22 +0100" MODIFIED_BY="Heather  Maxwell" NOTES="&lt;p&gt;Cambria RP, Brewster DC, Lauterbach SR, Kaufman JL, Geller S, Fan C-M, et al. Evolving experience with thoracic aortic stent graft repair. J Vasc Surg. 2002 Jun;35(6):1129-36.&lt;br&gt;Cambria RP. Brewster DC. Lauterbach SR. Kaufman JL. Geller S. Fan CM. Greenfield A. Hilgenberg A. Clouse WD. Evolving experience with thoracic aortic stent graft repair. [Clinical Trial. Clinical Trial, Phase II. Journal Article. Research Support, Non-U.S. Gov't] Journal of Vascular Surgery. 35(6):1129-36, 2002 Jun. &lt;br&gt;&lt;/p&gt;" NOTES_MODIFIED="2008-10-13 15:22:22 +0100" NOTES_MODIFIED_BY="Heather  Maxwell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cambria RP, Brewster DC, Lauterbach SR, Kaufman JL, Geller S, Fan C-M, et al</AU>
<TI>Evolving experience with thoracic aortic stent graft repair</TI>
<SO>Journal of Vascular Surgery</SO>
<YR>2002</YR>
<VL>35</VL>
<NO>6</NO>
<PG>1129-36</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2858475"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2858474"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dake-1998" MODIFIED="2008-10-19 03:55:22 +0100" MODIFIED_BY="[Empty name]" NAME="Dake 1998" YEAR="1998">
<REFERENCE MODIFIED="2008-10-19 03:55:22 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Dake MD, Miller DC, Mitchell RS, Semba CP, Moore KA, Sakai T. The &amp;quot;first generation&amp;quot; of endovascular stent-grafts for patients with aneurysms of the descending thoracic aorta. J Thorac Cardiovasc Surg. 1998 Nov;116(5):689-703; discussion -4.&lt;br&gt;Dake MD. Miller DC. Mitchell RS. Semba CP. Moore KA. Sakai T. The &amp;quot;first generation&amp;quot; of endovascular stent-grafts for patients with aneurysms of the descending thoracic aorta. [Journal Article] Journal of Thoracic &amp;amp; Cardiovascular Surgery. 116(5):689-703; discussion 703-4, 1998 Nov&lt;/p&gt;" NOTES_MODIFIED="2008-10-19 03:55:22 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dake MD, Miller DC, Mitchell RS, Semba CP, Moore KA, Sakai T</AU>
<TI>The "first generation" of endovascular stent-grafts for patients with aneurysms of the descending thoracic aorta</TI>
<SO>Journal of Thoracic and Cardiovascular Surgery</SO>
<YR>1998</YR>
<VL>116</VL>
<NO>5</NO>
<PG>689-703; discussion -4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2858477"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2858476"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fattori-2006" MODIFIED="2008-10-19 03:55:52 +0100" MODIFIED_BY="[Empty name]" NAME="Fattori 2006" YEAR="2006">
<REFERENCE MODIFIED="2008-10-19 03:55:52 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Fattori R, Nienaber CA, Rousseau H, Beregi J-P, Heijmen R, Grabenwoger M, et al. Results of endovascular repair of the thoracic aorta with the Talent Thoracic stent graft: the Talent Thoracic Retrospective Registry. J Thorac Cardiovasc Surg. 2006 Aug;132(2):332-9.&lt;br&gt;Fattori R. Nienaber CA. Rousseau H. Beregi JP. Heijmen R. Grabenwoger M. Piquet P. Lovato L. Dabbech C. Kische S. Gaxotte V. Schepens M. Ehrlich M. Bartoli JM. Talent Thoracic Retrospective Registry. Results of endovascular repair of the thoracic aorta with the Talent Thoracic stent graft: the Talent Thoracic Retrospective Registry. [Journal Article] Journal of Thoracic &amp;amp; Cardiovascular Surgery. 132(2):332-9, 2006 Aug. &lt;br&gt;&lt;/p&gt;" NOTES_MODIFIED="2008-10-19 03:55:52 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fattori R, Nienaber CA, Rousseau H, Beregi J-P, Heijmen R, Grabenwoger M, et al</AU>
<TI>Results of endovascular repair of the thoracic aorta with the Talent Thoracic stent graft: the Talent Thoracic Retrospective Registry</TI>
<SO>Journal of Thoracic and Cardiovascular Surgery</SO>
<YR>2006</YR>
<VL>132</VL>
<NO>2</NO>
<PG>332-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2858479"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2858478"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hassoun-2005" MODIFIED="2013-08-05 14:57:24 +0100" MODIFIED_BY="[Empty name]" NAME="Hassoun 2005" YEAR="2005">
<REFERENCE MODIFIED="2013-08-05 14:57:24 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Hassoun HT, Dake MD, Svensson LG, Greenberg RK, Cambria RP, Moore RD, et al. Multi-institutional pivotal trial of the Zenith TX2 thoracic aortic stent-graft for treatment of descending thoracic aortic aneurysms: clinical study design. Perspec. 2005 Sep;17(3):255-64.&lt;br&gt;Hassoun HT. Dake MD. Svensson LG. Greenberg RK. Cambria RP. Moore RD. Matsumura JS. Multi-institutional pivotal trial of the Zenith TX2 thoracic aortic stent-graft for treatment of descending thoracic aortic aneurysms: clinical study design. [Journal Article. Research Support, Non-U.S. Gov't] Perspectives in Vascular Surgery &amp;amp; Endovascular Therapy. 17(3):255-64, 2005 Sep. &lt;br&gt;&lt;/p&gt;" NOTES_MODIFIED="2013-08-05 14:57:24 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hassoun HT, Dake MD, Svensson LG, Greenberg RK, Cambria RP, Moore RD, et al</AU>
<TI>Multi-institutional pivotal trial of the Zenith TX2 thoracic aortic stent-graft for treatment of descending thoracic aortic aneurysms: clinical study design</TI>
<SO>Perspectives in Vascular Surgery and Endovascular Therapy</SO>
<YR>2005</YR>
<VL>17</VL>
<NO>3</NO>
<PG>255-64</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2858481"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2858480"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hassoun-2006" MODIFIED="2008-10-13 15:21:33 +0100" MODIFIED_BY="Heather  Maxwell" NAME="Hassoun 2006" YEAR="2006">
<REFERENCE MODIFIED="2008-10-13 15:21:33 +0100" MODIFIED_BY="Heather  Maxwell" NOTES="&lt;p&gt;Hassoun HT, Mitchell RS, Makaroun MS, Whiting AJ, Cardeira KR, Matsumura JS. Aortic neck morphology after endovascular repair of descending thoracic aortic aneurysms. J Vasc Surg. 2006 Jan;43(1):26-31.&lt;br&gt;Hassoun HT. Mitchell RS. Makaroun MS. Whiting AJ. Cardeira KR. Matsumura JS. Aortic neck morphology after endovascular repair of descending thoracic aortic aneurysms. [Clinical Trial. Journal Article. Multicenter Study. Research Support, Non-U.S. Gov't] Journal of Vascular Surgery. 43(1):26-31, 2006 Jan&lt;br&gt;&lt;/p&gt;" NOTES_MODIFIED="2008-10-13 15:21:33 +0100" NOTES_MODIFIED_BY="Heather  Maxwell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hassoun HT, Mitchell RS, Makaroun MS, Whiting AJ, Cardeira KR, Matsumura JS</AU>
<TI>Aortic neck morphology after endovascular repair of descending thoracic aortic aneurysms</TI>
<SO>Journal of Vascular Surgery</SO>
<YR>2006</YR>
<VL>43</VL>
<NO>1</NO>
<PG>26-31</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2858483"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2858482"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ince-2003" MODIFIED="2008-10-19 03:58:36 +0100" MODIFIED_BY="[Empty name]" NAME="Ince 2003" YEAR="2003">
<REFERENCE MODIFIED="2008-10-19 03:58:36 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Ince H, Petzsch M, Rehders T, Kische S, Korber T, Weber F, et al. Percutaneous endovascular repair of aneurysm after previous coarctation surgery.[see comment]. Circulation. 2003 Dec 16;108(24):2967-70.&lt;br&gt;Ince H. Petzsch M. Rehders T. Kische S. Korber T. Weber F. Nienaber CA. Percutaneous endovascular repair of aneurysm after previous coarctation surgery.[see comment]. [Clinical Trial. Journal Article] Circulation. 108(24):2967-70, 2003 Dec 16&lt;/p&gt;" NOTES_MODIFIED="2008-10-19 03:58:36 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ince H, Petzsch M, Rehders T, Kische S, Korber T, Weber F, et al</AU>
<TI>Percutaneous endovascular repair of aneurysm after previous coarctation surgery [see comment]</TI>
<SO>Circulation</SO>
<YR>2003</YR>
<VL>108</VL>
<NO>24</NO>
<PG>2967-70</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2858485"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2858484"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Makaroun-2005" MODIFIED="2008-10-13 15:23:21 +0100" MODIFIED_BY="Heather  Maxwell" NAME="Makaroun 2005" YEAR="2005">
<REFERENCE MODIFIED="2008-10-13 15:23:21 +0100" MODIFIED_BY="Heather  Maxwell" NOTES="&lt;p&gt;Makaroun MS. Dillavou ED. Kee ST. Sicard G. Chaikof E. Bavaria J. Williams D. Cambria RP. Mitchell RS. Endovascular treatment of thoracic aortic aneurysms: results of the phase II multicenter trial of the GORE TAG thoracic endoprosthesis. [Clinical Trial. Clinical Trial, Phase II. Journal Article. Multicenter Study. Research Support, Non-U.S. Gov't] Journal of Vascular Surgery. 41(1):1-9, 2005 Jan. &lt;br&gt;&lt;/p&gt;" NOTES_MODIFIED="2008-10-13 15:23:21 +0100" NOTES_MODIFIED_BY="Heather  Maxwell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Makaroun MS, Dillavou ED, Kee ST, Sicard G, Chaikof E, Bavaria J, et al</AU>
<TI>Endovascular treatment of thoracic aortic aneurysms: results of the phase II multicenter trial of the GORE TAG thoracic endoprosthesis</TI>
<SO>Journal of Vascular Surgery</SO>
<YR>2005</YR>
<VL>41</VL>
<NO>1</NO>
<PG>1-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2858487"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2858486"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mitchell-1999" MODIFIED="2008-10-13 15:23:33 +0100" MODIFIED_BY="Heather  Maxwell" NAME="Mitchell 1999" YEAR="1999">
<REFERENCE MODIFIED="2008-10-13 15:23:33 +0100" MODIFIED_BY="Heather  Maxwell" NOTES="&lt;p&gt;Mitchell RS. Miller DC. Dake MD. Semba CP. Moore KA. Sakai T. Thoracic aortic aneurysm repair with an endovascular stent graft: the &amp;quot;first generation&amp;quot;. [Clinical Trial. Journal Article] Annals of Thoracic Surgery. 67(6):1971-4; discussion 1979-80, 1999 Jun. &lt;br&gt;&lt;/p&gt;" NOTES_MODIFIED="2008-10-13 15:23:33 +0100" NOTES_MODIFIED_BY="Heather  Maxwell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mitchell RS, Miller DC, Dake MD, Semba CP, Moore KA, Sakai T</AU>
<TI>Thoracic aortic aneurysm repair with an endovascular stent graft: the "first generation"</TI>
<SO>Annals of Thoracic Surgery</SO>
<YR>1999</YR>
<VL>67</VL>
<NO>6</NO>
<PG>1971-4; discussion 9-80</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2858489"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2858488"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Najibi-2002" MODIFIED="2008-10-13 15:23:59 +0100" MODIFIED_BY="Heather  Maxwell" NAME="Najibi 2002" YEAR="2002">
<REFERENCE MODIFIED="2008-10-13 15:23:59 +0100" MODIFIED_BY="Heather  Maxwell" NOTES="&lt;p&gt;Najibi S. Terramani TT. Weiss VJ. Mac Donald MJ. Lin PH. Redd DC. Martin LG. Chaikof EL. Lumsden AB. Endoluminal versus open treatment of descending thoracic aortic aneurysms. [Comparative Study. Journal Article. Research Support, Non-U.S. Gov't] Journal of Vascular Surgery. 36(4):732-7, 2002 Oct. &lt;br&gt;&lt;/p&gt;" NOTES_MODIFIED="2008-10-13 15:23:59 +0100" NOTES_MODIFIED_BY="Heather  Maxwell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Najibi S, Terramani TT, Weiss VJ, Mac Donald MJ, Lin PH, Redd DC, et al</AU>
<TI>Endoluminal versus open treatment of descending thoracic aortic aneurysms</TI>
<SO>Journal of Vascular Surgery</SO>
<YR>2002</YR>
<VL>36</VL>
<NO>4</NO>
<PG>732-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2858491"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2858490"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wheatley-2006" MODIFIED="2008-10-19 03:59:20 +0100" MODIFIED_BY="[Empty name]" NAME="Wheatley 2006" YEAR="2006">
<REFERENCE MODIFIED="2008-10-19 03:59:20 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Wheatley GH, 3rd, Gurbuz AT, Rodriguez-Lopez JA, Ramaiah VG, Olsen D, Williams J, et al. Midterm outcome in 158 consecutive Gore TAG thoracic endoprostheses: single center experience. Ann Thorac Surg. 2006 May;81(5):1570-7; discussion 7.&lt;/p&gt;" NOTES_MODIFIED="2008-10-19 03:59:20 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wheatley GH 3rd, Gurbuz AT, Rodriguez-Lopez JA, Ramaiah VG, Olsen D, Williams J, et al</AU>
<TI>Midterm outcome in 158 consecutive Gore TAG thoracic endoprostheses: single center experience</TI>
<SO>Annals of Thoracic Surgery</SO>
<YR>2006</YR>
<VL>81</VL>
<NO>5</NO>
<PG>1570-7; discussion 7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2858493"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2858492"/></IDENTIFIERS>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2016-05-31 11:46:49 +0100" MODIFIED_BY="Cathryn  Broderick">
<ADDITIONAL_REFERENCES MODIFIED="2016-05-31 11:46:49 +0100" MODIFIED_BY="Cathryn  Broderick">
<REFERENCE ID="REF-Abraha-2015" MODIFIED="2016-05-04 11:12:18 +0100" MODIFIED_BY="Cathryn  Broderick" NAME="Abraha 2015" TYPE="JOURNAL_ARTICLE">
<AU>Abraha I, Cherubini A, Cozzolino F, De Florio R, Luchetta ML, Rimland JM, et al</AU>
<TI>Deviation from intention to treat analysis in randomised trials and treatment effect estimates: meta-epidemiological study</TI>
<SO>British Medical Journal (Clinical research ed.)</SO>
<YR>2015</YR>
<VL>350</VL>
<PG>h2445</PG>
<IDENTIFIERS MODIFIED="2016-04-16 14:35:26 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="26016488"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Atkins-2004" MODIFIED="2016-05-16 14:49:14 +0100" MODIFIED_BY="[Empty name]" NAME="Atkins 2004" TYPE="JOURNAL_ARTICLE">
<AU>Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al</AU>
<TI>GRADE Working Group. Grading quality of evidence and strength of recommendations</TI>
<SO>British Medical Journal</SO>
<YR>2004</YR>
<VL>328</VL>
<NO>7454</NO>
<PG>1490-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bickerstaff-1982" MODIFIED="2008-10-13 15:24:50 +0100" MODIFIED_BY="Heather  Maxwell" NAME="Bickerstaff 1982" TYPE="JOURNAL_ARTICLE">
<AU>Bickerstaff LK, Pairolero PC, Hollier LH, Melton LJ, Van Peenen HJ, Cherry KJ, et al</AU>
<TI>Thoracic aortic aneurysms: a population-based study</TI>
<SO>Surgery</SO>
<YR>1982</YR>
<VL>92</VL>
<NO>6</NO>
<PG>1103-8</PG>
<IDENTIFIERS MODIFIED="2008-10-13 15:24:50 +0100" MODIFIED_BY="Heather  Maxwell"/>
</REFERENCE>
<REFERENCE ID="REF-Cambria-1995" MODIFIED="2008-10-10 15:01:08 +0100" MODIFIED_BY="Heather  Maxwell" NAME="Cambria 1995" TYPE="JOURNAL_ARTICLE">
<AU>Cambria RA, Gloviczki P, Stanson AW, Cherry KJ Jr, Bower TC, Hallett JW Jr, et al</AU>
<TI>Outcome and expansion rate of 57 thoracoabdominal aortic aneurysms managed nonoperatively</TI>
<SO>American Journal of Surgery</SO>
<YR>1995</YR>
<VL>170</VL>
<NO>2</NO>
<PG>213-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Clouse-1998" MODIFIED="2008-10-19 05:53:41 +0100" MODIFIED_BY="[Empty name]" NAME="Clouse 1998" TYPE="JOURNAL_ARTICLE">
<AU>Clouse WD, Hallett JW Jr, Schaff HV, Gayari MM, Ilstrup DM, Melton LJ 3rd</AU>
<TI>Improved prognosis of thoracic aortic aneurysms: a population-based study</TI>
<SO>JAMA</SO>
<YR>1998</YR>
<VL>280</VL>
<NO>22</NO>
<PG>1926-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Coady-1997" MODIFIED="2008-10-19 03:59:44 +0100" MODIFIED_BY="[Empty name]" NAME="Coady 1997" TYPE="JOURNAL_ARTICLE">
<AU>Coady MA, Rizzo JA, Hammond GL, Mandapati D, Darr U, Kopf GS, et al</AU>
<TI>What is the appropriate size criterion for resection of thoracic aortic aneurysms?</TI>
<SO>Journal of Thoracic and Cardiovascular Surgery</SO>
<YR>1997</YR>
<VL>113</VL>
<NO>3</NO>
<PG>476-91; discussion 489-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Coselli-2000" MODIFIED="2008-10-10 15:01:22 +0100" MODIFIED_BY="Heather  Maxwell" NAME="Coselli 2000" TYPE="JOURNAL_ARTICLE">
<AU>Coselli JS, LeMaire SA, Miller CC, 3rd, Schmittling ZC, Koksoy C, Pagan J, et al</AU>
<TI>Mortality and paraplegia after thoracoabdominal aortic aneurysm repair: a risk factor analysis</TI>
<SO>Annals of Thoracic Surgery</SO>
<YR>2000</YR>
<VL>69</VL>
<NO>2</NO>
<PG>409-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Crawford-1986" MODIFIED="2008-10-13 15:25:58 +0100" MODIFIED_BY="Heather  Maxwell" NAME="Crawford 1986" TYPE="JOURNAL_ARTICLE">
<AU>Crawford ES, DeNatale RW</AU>
<TI>Thoracoabdominal aortic aneurysm: observations regarding the natural course of the disease</TI>
<SO>Journal of Vascular Surgery</SO>
<YR>1986</YR>
<VL>3</VL>
<NO>4</NO>
<PG>578-82</PG>
<IDENTIFIERS MODIFIED="2008-10-13 15:25:58 +0100" MODIFIED_BY="Heather  Maxwell"/>
</REFERENCE>
<REFERENCE ID="REF-Dake-1994" MODIFIED="2008-10-10 15:01:30 +0100" MODIFIED_BY="Heather  Maxwell" NAME="Dake 1994" TYPE="JOURNAL_ARTICLE">
<AU>Dake MD, Miller DC, Semba CP, Mitchell RS, Walker PJ, Liddell RP</AU>
<TI>Transluminal placement of endovascular stent-grafts for the treatment of descending thoracic aortic aneurysms</TI>
<SO>New England Journal of Medicine</SO>
<YR>1994</YR>
<VL>331</VL>
<NO>26</NO>
<PG>1729-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Deeb-1995" MODIFIED="2008-10-10 15:01:34 +0100" MODIFIED_BY="Heather  Maxwell" NAME="Deeb 1995" TYPE="JOURNAL_ARTICLE">
<AU>Deeb GM, Jenkins E, Bolling SF, Brunsting LA, Williams DM, Quint LE, et al</AU>
<TI>Retrograde cerebral perfusion during hypothermic circulatory arrest reduces neurologic morbidity</TI>
<SO>Journal of Thoracic and Cardiovascular Surgery</SO>
<YR>1995</YR>
<VL>109</VL>
<NO>2</NO>
<PG>259-68</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Demers-2004" MODIFIED="2008-10-10 15:01:37 +0100" MODIFIED_BY="Heather  Maxwell" NAME="Demers 2004" TYPE="JOURNAL_ARTICLE">
<AU>Demers P, Miller DC, Mitchell RS, Kee ST, Sze D, Razavi MK, et al</AU>
<TI>Midterm results of endovascular repair of descending thoracic aortic aneurysms with first-generation stent grafts</TI>
<SO>Journal of Thoracic and Cardiovascular Surgery</SO>
<YR>2004</YR>
<VL>127</VL>
<NO>3</NO>
<PG>664-73</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ehrlich-1998" MODIFIED="2008-10-13 15:26:27 +0100" MODIFIED_BY="Heather  Maxwell" NAME="Ehrlich 1998" TYPE="JOURNAL_ARTICLE">
<AU>Ehrlich M, Grabenwoeger M, Cartes-Zumelzu F, Grimm M, Petzl D, Lammer J, et al</AU>
<TI>Endovascular stent graft repair for aneurysms on the descending thoracic aorta</TI>
<SO>Annals of Thoracic Surgery</SO>
<YR>1998</YR>
<VL>66</VL>
<NO>1</NO>
<PG>19-24; discussion 24-5</PG>
<IDENTIFIERS MODIFIED="2008-10-13 15:26:27 +0100" MODIFIED_BY="Heather  Maxwell"/>
</REFERENCE>
<REFERENCE ID="REF-GRADEproGDT" MODIFIED="2016-05-31 11:46:49 +0100" MODIFIED_BY="Cathryn  Broderick" NAME="GRADEproGDT" TYPE="COMPUTER_PROGRAM">
<TI>GRADEpro GDT: GRADEpro Guideline Development Tool [Software]. McMaster University (developed by Evidence Prime, Inc.)</TI>
<YR>2015</YR>
<PB>Available from www.gradepro.org</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Greenberg-2000" MODIFIED="2008-10-13 15:26:37 +0100" MODIFIED_BY="Heather  Maxwell" NAME="Greenberg 2000" TYPE="JOURNAL_ARTICLE">
<AU>Greenberg R, Resch T, Nyman U, Lindh M, Brunkwall J, Brunkwall P, et al</AU>
<TI>Endovascular repair of descending thoracic aortic aneurysms: an early experience with intermediate-term follow-up</TI>
<SO>Journal of Vascular Surgery</SO>
<YR>2000</YR>
<VL>31</VL>
<NO>1 Pt 1</NO>
<PG>147-56</PG>
<IDENTIFIERS MODIFIED="2008-10-13 15:26:37 +0100" MODIFIED_BY="Heather  Maxwell"/>
</REFERENCE>
<REFERENCE ID="REF-Greenhalgh-2004" MODIFIED="2008-10-13 15:27:03 +0100" MODIFIED_BY="Heather  Maxwell" NAME="Greenhalgh 2004" TYPE="JOURNAL_ARTICLE">
<AU>Greenhalgh RM, Brown LC, Kwong GP, Powell JT, Thompson SG</AU>
<TI>Comparison of endovascular aneurysm repair with open repair in patients with abdominal aortic aneurysm (EVAR trial 1), 30-day operative mortality results: randomised controlled trial</TI>
<SO>Lancet</SO>
<YR>2004</YR>
<VL>364</VL>
<NO>9437</NO>
<PG>843-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Griepp-1999" MODIFIED="2008-10-10 15:01:56 +0100" MODIFIED_BY="Heather  Maxwell" NAME="Griepp 1999" TYPE="JOURNAL_ARTICLE">
<AU>Griepp RB, Ergin MA, Galla JD, Lansman SL, McCullough JN, Nguyen KH, et al</AU>
<TI>Natural history of descending thoracic and thoracoabdominal aneurysms</TI>
<SO>Annals of Thoracic Surgery</SO>
<YR>1999</YR>
<VL>67</VL>
<NO>6</NO>
<PG>1927-30; discussion 1953-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hamerlijnck-1989" MODIFIED="2008-10-10 15:01:59 +0100" MODIFIED_BY="Heather  Maxwell" NAME="Hamerlijnck 1989" TYPE="JOURNAL_ARTICLE">
<AU>Hamerlijnck RP, Rutsaert RR, De Geest R, Brutel de la Riviere A, Defauw JJ, Vermeulen FE</AU>
<TI>Surgical correction of descending thoracic aortic aneurysms under simple aortic cross-clamping</TI>
<SO>Journal of Vascular Surgery</SO>
<YR>1989</YR>
<VL>9</VL>
<NO>4</NO>
<PG>568-73</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2016-05-31 11:45:18 +0100" MODIFIED_BY="Cathryn  Broderick" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins JPT, Green S (editors)</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 [updated March 2011]. The Cochrane Collaboration, 2011</TI>
<SO>Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hirose-1993" MODIFIED="2008-10-13 15:27:35 +0100" MODIFIED_BY="Heather  Maxwell" NAME="Hirose 1993" TYPE="JOURNAL_ARTICLE">
<AU>Hirose Y, Hamada S, Takamiya M, Imakita S, Naito H</AU>
<TI>Growth rates of aortic aneurysms as a risk factor in rupture: an evaluation with CT</TI>
<SO>Nippon Igaku Hoshasen Gakkai Zasshi</SO>
<YR>1993</YR>
<VL>53</VL>
<NO>6</NO>
<PG>635-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Huynh-2002" MODIFIED="2008-10-10 15:02:08 +0100" MODIFIED_BY="Heather  Maxwell" NAME="Huynh 2002" TYPE="JOURNAL_ARTICLE">
<AU>Huynh TT, Miller CC 3rd, Estrera AL, Porat EE, Safi HJ</AU>
<TI>Thoracoabdominal and descending thoracic aortic aneurysm surgery in patients aged 79 years or older</TI>
<SO>Journal of Vascular Surgery</SO>
<YR>2002</YR>
<VL>36</VL>
<NO>3</NO>
<PG>469-75</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Johansson-1995" MODIFIED="2008-10-10 15:02:12 +0100" MODIFIED_BY="Heather  Maxwell" NAME="Johansson 1995" TYPE="JOURNAL_ARTICLE">
<AU>Johansson G, Markstrom U, Swedenborg J</AU>
<TI>Ruptured thoracic aortic aneurysms: a study of incidence and mortality rates</TI>
<SO>Journal of Vascular Surgery</SO>
<YR>1995</YR>
<VL>21</VL>
<NO>6</NO>
<PG>985-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Joyce-1964" MODIFIED="2008-10-19 04:01:38 +0100" MODIFIED_BY="[Empty name]" NAME="Joyce 1964" TYPE="JOURNAL_ARTICLE">
<AU>Joyce JW, Fairbairn JF II, Kincaid OW, Juergen JL</AU>
<TI>Aneurysms of the thoracic aorta. A clinical study with special reference to prognosis</TI>
<SO>Circulation</SO>
<YR>1964</YR>
<VL>29</VL>
<NO>2</NO>
<PG>176-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Juvonen-1997" MODIFIED="2008-10-10 15:02:20 +0100" MODIFIED_BY="Heather  Maxwell" NAME="Juvonen 1997" TYPE="JOURNAL_ARTICLE">
<AU>Juvonen T, Ergin MA, Galla JD, Lansman SL, Nguyen KH, McCullough JN, et al</AU>
<TI>Prospective study of the natural history of thoracic aortic aneurysms</TI>
<SO>Annals of Thoracic Surgery</SO>
<YR>1997</YR>
<VL>63</VL>
<NO>6</NO>
<PG>1533-45</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-LeMaire-2003" MODIFIED="2008-10-13 15:28:07 +0100" MODIFIED_BY="Heather  Maxwell" NAME="LeMaire 2003" TYPE="JOURNAL_ARTICLE">
<AU>LeMaire SA, Miller CC 3rd, Conklin LD, Schmittling ZC, Coselli JS</AU>
<TI>Estimating group mortality and paraplegia rates after thoracoabdominal aortic aneurysm repair</TI>
<SO>Annals of Thoracic Surgery</SO>
<YR>2003</YR>
<VL>75</VL>
<NO>2</NO>
<PG>508-13</PG>
<IDENTIFIERS MODIFIED="2008-10-13 15:28:07 +0100" MODIFIED_BY="Heather  Maxwell"/>
</REFERENCE>
<REFERENCE ID="REF-Lobato-1998" MODIFIED="2008-10-10 15:02:29 +0100" MODIFIED_BY="Heather  Maxwell" NAME="Lobato 1998" TYPE="JOURNAL_ARTICLE">
<AU>Lobato AC, Puech-Leao P</AU>
<TI>Predictive factors for rupture of thoracoabdominal aortic aneurysm</TI>
<SO>Journal of Vascular Surgery</SO>
<YR>1998</YR>
<VL>27</VL>
<NO>3</NO>
<PG>446-53</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Marcheix-2006" MODIFIED="2008-10-10 15:02:32 +0100" MODIFIED_BY="Heather  Maxwell" NAME="Marcheix 2006" TYPE="JOURNAL_ARTICLE">
<AU>Marcheix B, Dambrin C, Bolduc J-P, Arnaud C, Cron C, Hollington L, et al</AU>
<TI>Midterm results of endovascular treatment of atherosclerotic aneurysms of the descending thoracic aorta</TI>
<SO>Journal of Thoracic and Cardiovascular Surgery</SO>
<YR>2006</YR>
<VL>132</VL>
<NO>5</NO>
<PG>1030-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Neuhauser-2005" MODIFIED="2008-10-10 15:02:37 +0100" MODIFIED_BY="Heather  Maxwell" NAME="Neuhauser 2005" TYPE="JOURNAL_ARTICLE">
<AU>Neuhauser B, Czermak BV, Fish J, Perkmann R, Jaschke W, Chemelli A, et al</AU>
<TI>Type A dissection following endovascular thoracic aortic stent-graft repair</TI>
<SO>Journal of Endovascular Therapy</SO>
<YR>2005</YR>
<VL>12</VL>
<NO>1</NO>
<PG>74-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Parodi-1991" MODIFIED="2008-10-10 15:02:41 +0100" MODIFIED_BY="Heather  Maxwell" NAME="Parodi 1991" TYPE="JOURNAL_ARTICLE">
<AU>Parodi JC, Palmaz JC, Barone HD, Palmaz JC, Barone HD</AU>
<TI>Transfemoral intraluminal graft implantation for abdominal aortic aneurysms</TI>
<SO>Annals of Vascular Surgery</SO>
<YR>1991</YR>
<VL>5</VL>
<NO>6</NO>
<PG>491-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Perko-1995" MODIFIED="2008-10-19 05:55:26 +0100" MODIFIED_BY="[Empty name]" NAME="Perko 1995" TYPE="JOURNAL_ARTICLE">
<AU>Perko MJ, Norgaard M, Herzog TM, Olsen PS, Schroeder TV, Pettersson G</AU>
<TI>Unoperated aortic aneurysm: a survey of 170 patients</TI>
<SO>Annals of Thoracic Surgery</SO>
<YR>1995</YR>
<VL>59</VL>
<NO>5</NO>
<PG>1204-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Prinssen-2004" MODIFIED="2008-10-10 15:02:48 +0100" MODIFIED_BY="Heather  Maxwell" NAME="Prinssen 2004" TYPE="JOURNAL_ARTICLE">
<AU>Prinssen M, Verhoeven EL, Buth J, Cuypers PW, van Sambeek MR, Balm R, et al</AU>
<TI>A randomized trial comparing conventional and endovascular repair of abdominal aortic aneurysms</TI>
<SO>New England Journal of Medicine</SO>
<YR>2004</YR>
<VL>351</VL>
<NO>16</NO>
<PG>1607-18</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Savovic-2012" MODIFIED="2016-04-16 14:35:36 +0100" MODIFIED_BY="[Empty name]" NAME="Savovic 2012" TYPE="JOURNAL_ARTICLE">
<AU>Savovic J, Jones H, Altman D, Harris R, Juni P, Pildal J, et al</AU>
<TI>Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies</TI>
<SO>Health technology assessment (Winchester, England)</SO>
<YR>2012</YR>
<VL>16</VL>
<NO>35</NO>
<PG>1-82</PG>
<IDENTIFIERS MODIFIED="2016-04-16 14:35:26 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="22989478"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Svensson-2008" MODIFIED="2008-10-19 04:02:42 +0100" MODIFIED_BY="[Empty name]" NAME="Svensson 2008" TYPE="JOURNAL_ARTICLE">
<AU>Svensson LG, Kouchoukos NT, Miller DC, Bavaria JE, Coselli JS, Curi MA, et al</AU>
<TI>Expert consensus document on the treatment of descending thoracic aortic disease using endovascular stent-grafts</TI>
<SO>Annals of Thoracic Surgery</SO>
<YR>2008</YR>
<VL>85 Suppl 1</VL>
<PG>1-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Thurnher-2002" MODIFIED="2008-10-10 15:02:58 +0100" MODIFIED_BY="Heather  Maxwell" NAME="Thurnher 2002" TYPE="JOURNAL_ARTICLE">
<AU>Thurnher SA, Grabenwoger M</AU>
<TI>Endovascular treatment of thoracic aortic aneurysms: a review</TI>
<SO>European Radiology</SO>
<YR>2002</YR>
<VL>12</VL>
<NO>6</NO>
<PG>1370-87</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wood-2008" MODIFIED="2016-05-04 11:14:59 +0100" MODIFIED_BY="Cathryn  Broderick" NAME="Wood 2008" TYPE="JOURNAL_ARTICLE">
<AU>Wood L, Egger M, Gluud LL, Schulz KF, Juni P, Altman DG, et al</AU>
<TI>Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study</TI>
<SO>British Medical Journal (Clinical research ed.)</SO>
<YR>2008</YR>
<VL>336</VL>
<NO>7644</NO>
<PG>601-5</PG>
<IDENTIFIERS MODIFIED="2016-04-16 14:35:26 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="18316340"/></IDENTIFIERS>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2016-05-04 10:35:10 +0100" MODIFIED_BY="Cathryn  Broderick">
<REFERENCE ID="REF-Abraha-2007" MODIFIED="2016-05-04 10:35:10 +0100" MODIFIED_BY="Cathryn  Broderick" NAME="Abraha 2007" TYPE="COCHRANE_PROTOCOL">
<AU>Abraha I, Romagnoli C, Montedori A, Cirocchi R</AU>
<TI>Thoracic stent graft versus surgery for thoracic aneurysm</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2007</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2016-05-04 10:35:10 +0100" MODIFIED_BY="Cathryn  Broderick"><IDENTIFIER MODIFIED="2016-05-04 10:35:10 +0100" MODIFIED_BY="Cathryn  Broderick" TYPE="DOI" VALUE="10.1002/14651858.CD006796"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Abraha-2009" MODIFIED="2013-06-25 13:43:08 +0100" MODIFIED_BY="Cathryn  A Broderick" NAME="Abraha 2009" TYPE="COCHRANE_REVIEW">
<AU>Abraha I, Romagnoli C, Montedori A, Cirocchi R</AU>
<TI>Thoracic stent graft versus surgery for thoracic aneurysm</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2009</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2013-06-25 13:43:08 +0100" MODIFIED_BY="Cathryn  A Broderick"><IDENTIFIER MODIFIED="2013-06-25 13:43:08 +0100" MODIFIED_BY="Cathryn  A Broderick" TYPE="DOI" VALUE="10.1002/14651858.CD006796.pub2"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Abraha-2013" MODIFIED="2016-01-21 10:19:15 +0000" MODIFIED_BY="Cathryn  Broderick" NAME="Abraha 2013" TYPE="COCHRANE_REVIEW">
<AU>Abraha I, Romagnoli C, Montedori A, Cirocchi R</AU>
<TI>Thoracic stent graft versus surgery for thoracic aneurysm</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2013</YR>
<NO>9</NO>
<IDENTIFIERS MODIFIED="2016-01-21 10:17:03 +0000" MODIFIED_BY="Cathryn  Broderick"><IDENTIFIER MODIFIED="2016-01-21 10:17:03 +0000" MODIFIED_BY="Cathryn  Broderick" TYPE="DOI" VALUE="10.1002/14651858.CD006796.pub3"/></IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2016-05-16 14:49:55 +0100" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2016-05-16 14:49:55 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2016-05-16 14:49:55 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Appoo-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-05-16 14:49:55 +0100" MODIFIED_BY="[Empty name]">
<P>Case series of 99 patients with descending thoracic aneurysms treated with first or second generation endografts (1999 - 2005)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-05-16 14:49:53 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Azizzadeh-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-05-16 14:49:53 +0100" MODIFIED_BY="[Empty name]">
<P>Case-control study. Analysis of 18 patients with delayed neurologic deficit after open cardiovascular surgery for thoracoabdominal or thoracic aortic repair</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-05-16 14:49:52 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bavaria-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-05-16 14:49:52 +0100" MODIFIED_BY="[Empty name]">
<P>Multicentre non-randomised controlled trial of 140 consecutive patients with descending thoracic aneurysms treated with EVAR compared with 94 retrospective case series treated with open cardiovascular surgery for thoracoabdominal or thoracic aortic repair</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-05-16 14:49:51 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cambria-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-05-16 14:49:51 +0100" MODIFIED_BY="[Empty name]">
<P>Retrospective data on 28 patients treated with EVAR for thoracoabdominal aneurysm</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-05-16 14:49:49 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dake-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-05-16 14:49:49 +0100" MODIFIED_BY="[Empty name]">
<P>Prospective uncontrolled clinical trial of 103 patients treated with EVAR for thoracoabdominal aneurysms</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-05-16 14:49:48 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fattori-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-05-16 14:49:48 +0100" MODIFIED_BY="[Empty name]">
<P>Register data of 457 consecutive patients (113 emergency and 334 elective cases) who received an endovascular Talent device</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-05-16 14:49:48 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hassoun-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-05-16 14:49:48 +0100" MODIFIED_BY="[Empty name]">
<P>Ongoing, prospective non-randomised phase II trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-05-16 14:49:45 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hassoun-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-05-16 14:49:45 +0100" MODIFIED_BY="[Empty name]">
<P>Retrospective clinical trial involving 139 patients who underwent endovascular descending thoracic aortic repair</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-05-16 14:49:44 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ince-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-05-16 14:49:44 +0100" MODIFIED_BY="[Empty name]">
<P>Retrospective analysis of six patients treated with EVAR for aortic aneurysm after previous coarctation surgery</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-05-16 14:49:44 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Makaroun-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-05-16 14:49:44 +0100" MODIFIED_BY="[Empty name]">
<P>Prospective non-randomised uncontrolled trial of 139 patients treated with Gore-TAG device</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-05-16 14:49:43 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mitchell-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-05-16 14:49:43 +0100" MODIFIED_BY="[Empty name]">
<P>Prospective consecutive treatment of 103 patients with home-made first-generation device</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-05-16 14:49:42 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Najibi-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-05-16 14:49:42 +0100" MODIFIED_BY="[Empty name]">
<P>Non-randomised controlled trial of 19 patients receiving endovascular treatment and 10 historic controls receiving open surgical repair</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-05-16 14:49:41 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wheatley-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-05-16 14:49:41 +0100" MODIFIED_BY="[Empty name]">
<P>Non-randomised multi-institutional analysis of 158 consecutive patients treated with Gore-TAG device</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES"/>
<FIGURES MODIFIED="2016-05-16 14:41:39 +0100" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Flowchart.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2016-05-16 14:41:39 +0100" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Study flow diagram.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAArYAAAI3CAYAAABu7xiRAABJzElEQVR42u3df8QV+f8//jdJkiSS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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2016-05-04 19:53:04 +0100" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2016-05-04 19:53:04 +0100" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2016-01-19 14:16:11 +0000" MODIFIED_BY="Karen Welch">CRS search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2016-05-04 19:53:04 +0100" MODIFIED_BY="[Empty name]">
<TABLE COLS="3" ROWS="31">
<TR>
<TD COLSPAN="2">
<P>Search run on Tue Jan 19 2016</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>#1</P>
</TD>
<TD>
<P>MESH DESCRIPTOR Aortic Aneurysm, Thoracic EXPLODE ALL TREES</P>
</TD>
<TD ALIGN="RIGHT">
<P>52</P>
</TD>
</TR>
<TR>
<TD>
<P>#2</P>
</TD>
<TD>
<P>MESH DESCRIPTOR Aorta, Thoracic</P>
</TD>
<TD ALIGN="RIGHT">
<P>139</P>
</TD>
</TR>
<TR>
<TD>
<P>#3</P>
</TD>
<TD>
<P>(thorac* near aneurysm):TI,AB,KY</P>
</TD>
<TD ALIGN="RIGHT">
<P>68</P>
</TD>
</TR>
<TR>
<TD>
<P>#4</P>
</TD>
<TD>
<P>(thoracic near3 (balloon* or dilat* or bulg*)):TI,AB,KY</P>
</TD>
<TD ALIGN="RIGHT">
<P>7</P>
</TD>
</TR>
<TR>
<TD>
<P>#5</P>
</TD>
<TD>
<P>TAA:TI,AB,KY</P>
</TD>
<TD ALIGN="RIGHT">
<P>134</P>
</TD>
</TR>
<TR>
<TD>
<P>#6</P>
</TD>
<TD>
<P>#1 OR #2 OR #3 OR #4 OR #5</P>
</TD>
<TD ALIGN="RIGHT">
<P>343</P>
</TD>
</TR>
<TR>
<TD>
<P>#7</P>
</TD>
<TD>
<P>MESH DESCRIPTOR Angioplasty EXPLODE ALL TREES</P>
</TD>
<TD ALIGN="RIGHT">
<P>4101</P>
</TD>
</TR>
<TR>
<TD>
<P>#8</P>
</TD>
<TD>
<P>(angioplas* or percutan* or PTA or venoplasty):TI,AB,KY</P>
</TD>
<TD ALIGN="RIGHT">
<P>12137</P>
</TD>
</TR>
<TR>
<TD>
<P>#9</P>
</TD>
<TD>
<P>(recanali* or revascular*):TI,AB,KY</P>
</TD>
<TD ALIGN="RIGHT">
<P>6550</P>
</TD>
</TR>
<TR>
<TD>
<P>#10</P>
</TD>
<TD>
<P>dilat*:TI,AB,KY</P>
</TD>
<TD ALIGN="RIGHT">
<P>6912</P>
</TD>
</TR>
<TR>
<TD>
<P>#11</P>
</TD>
<TD>
<P>(balloon or baloon):TI,AB,KY</P>
</TD>
<TD ALIGN="RIGHT">
<P>6481</P>
</TD>
</TR>
<TR>
<TD>
<P>#12</P>
</TD>
<TD>
<P>MESH DESCRIPTOR Endovascular Procedures</P>
</TD>
<TD ALIGN="RIGHT">
<P>168</P>
</TD>
</TR>
<TR>
<TD>
<P>#13</P>
</TD>
<TD>
<P>endovascular:TI,AB,KY</P>
</TD>
<TD ALIGN="RIGHT">
<P>1171</P>
</TD>
</TR>
<TR>
<TD>
<P>#14</P>
</TD>
<TD>
<P>MESH DESCRIPTOR Blood Vessel Prosthesis EXPLODE ALL TREES</P>
</TD>
<TD ALIGN="RIGHT">
<P>406</P>
</TD>
</TR>
<TR>
<TD>
<P>#15</P>
</TD>
<TD>
<P>MESH DESCRIPTOR Blood Vessel Prosthesis Implantation EXPLODE ALL TREES</P>
</TD>
<TD ALIGN="RIGHT">
<P>389</P>
</TD>
</TR>
<TR>
<TD>
<P>#16</P>
</TD>
<TD>
<P>MESH DESCRIPTOR Stents EXPLODE ALL TREES</P>
</TD>
<TD ALIGN="RIGHT">
<P>3123</P>
</TD>
</TR>
<TR>
<TD>
<P>#17</P>
</TD>
<TD>
<P>endoluminal:TI,AB,KY</P>
</TD>
<TD ALIGN="RIGHT">
<P>124</P>
</TD>
</TR>
<TR>
<TD>
<P>#18</P>
</TD>
<TD>
<P>(stent*):TI,AB,KY</P>
</TD>
<TD ALIGN="RIGHT">
<P>6755</P>
</TD>
</TR>
<TR>
<TD>
<P>#19</P>
</TD>
<TD>
<P>(endostent*):TI,AB,KY</P>
</TD>
<TD ALIGN="RIGHT">
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>#20</P>
</TD>
<TD>
<P>(graft*):TI,AB,KY</P>
</TD>
<TD ALIGN="RIGHT">
<P>15917</P>
</TD>
</TR>
<TR>
<TD>
<P>#21</P>
</TD>
<TD>
<P>(endograft*):TI,AB,KY</P>
</TD>
<TD ALIGN="RIGHT">
<P>57</P>
</TD>
</TR>
<TR>
<TD>
<P>#22</P>
</TD>
<TD>
<P>(endoprosthe*):TI,AB,KY</P>
</TD>
<TD ALIGN="RIGHT">
<P>230</P>
</TD>
</TR>
<TR>
<TD>
<P>#23</P>
</TD>
<TD>
<P>(EVAR):TI,AB,KY</P>
</TD>
<TD ALIGN="RIGHT">
<P>98</P>
</TD>
</TR>
<TR>
<TD>
<P>#24</P>
</TD>
<TD>
<P>(EVRAR):TI,AB,KY</P>
</TD>
<TD ALIGN="RIGHT">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>#25</P>
</TD>
<TD>
<P>(TEVAR):TI,AB,KY</P>
</TD>
<TD ALIGN="RIGHT">
<P>24</P>
</TD>
</TR>
<TR>
<TD>
<P>#26</P>
</TD>
<TD>
<P>#7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #18 OR #19 OR #20 OR #21 OR #22 OR #23 OR #24 OR #25</P>
</TD>
<TD ALIGN="RIGHT">
<P>40372</P>
</TD>
</TR>
<TR>
<TD>
<P>#27</P>
</TD>
<TD>
<P>#6 AND #26</P>
</TD>
<TD ALIGN="RIGHT">
<P>80</P>
</TD>
</TR>
<TR>
<TD>
<P>#28</P>
</TD>
<TD>
<P>* NOT SR-PVD:CC AND 28/03/2013 TO 29/02/2016:DL</P>
</TD>
<TD ALIGN="RIGHT">
<P>240623</P>
</TD>
</TR>
<TR>
<TD>
<P>#31</P>
</TD>
<TD>
<P>#27 AND #28</P>
</TD>
<TD ALIGN="RIGHT">
<P>30</P>
</TD>
</TR>
</TABLE>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS>
<EXTENSION ID="FLOW_1" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="1">
<FLOWCHARTBOX TEXT="&lt;p&gt;0 studies included &lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;0 studies included in previous version of the review&lt;/p&gt;"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;0 new studies included in qualitative synthesis&lt;/p&gt;" WIDTH="161">
<FLOWCHARTBOX TEXT="&lt;p&gt;2 full-text articles assessed for eligibility by authors&lt;/p&gt;" WIDTH="167">
<FLOWCHARTBOX TEXT="&lt;p&gt;32 reports screend by the CIS&lt;/p&gt;" WIDTH="170">
<FLOWCHARTBOX TEXT="&lt;p&gt;32 reports after duplicates removed&lt;/p&gt;" WIDTH="172">
<FLOWCHARTBOX TEXT="&lt;p&gt;30 reports identified from the CRS search&lt;/p&gt;" WIDTH="120"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;2 additional reports identified from the Specialised Register&lt;/p&gt;" WIDTH="132"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;30 reports not relevant&lt;/p&gt;" WIDTH="144"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;2 reports assessed as not relevant&lt;/p&gt;" WIDTH="145"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
</EXTENSIONS>
</COCHRANE_REVIEW>